Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Downgrades NeuBase Therapeutics to Perform

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.
byBenzinga Newsdesk
October 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0